Timing the initiation of multiple myeloma

Author:

Rustad Even H.ORCID,Yellapantula Venkata,Leongamornlert Daniel,Bolli Niccolò,Ledergor GuyORCID,Nadeu FerranORCID,Angelopoulos NicosORCID,Dawson Kevin J.,Mitchell Thomas J.ORCID,Osborne Robert J.,Ziccheddu Bachisio,Carniti Cristiana,Montefusco Vittorio,Corradini PaoloORCID,Anderson Kenneth C.,Moreau Philippe,Papaemmanuil Elli,Alexandrov Ludmil B.ORCID,Puente Xose S.ORCID,Campo EliasORCID,Siebert Reiner,Avet-Loiseau Herve,Landgren OlaORCID,Munshi Nikhil,Campbell Peter J.ORCID,Maura FrancescoORCID

Abstract

AbstractThe evolution and progression of multiple myeloma and its precursors over time is poorly understood. Here, we investigate the landscape and timing of mutational processes shaping multiple myeloma evolution in a large cohort of 89 whole genomes and 973 exomes. We identify eight processes, including a mutational signature caused by exposure to melphalan. Reconstructing the chronological activity of each mutational signature, we estimate that the initial transformation of a germinal center B-cell usually occurred during the first 2nd-3rd decades of life. We define four main patterns of activation-induced deaminase (AID) and apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC) mutagenesis over time, including a subset of patients with evidence of prolonged AID activity during the pre-malignant phase, indicating antigen-responsiveness and germinal center reentry. Our findings provide a framework to study the etiology of multiple myeloma and explore strategies for prevention and early detection.

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Reference57 articles.

1. McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present. Future Cell 168, 613–628 (2017).

2. Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122–128 (2020).

3. Yates, L. R. & Campbell, P. J. Evolution of the cancer genome. Nat. Rev. Genet. 13, 795–806 (2012).

4. Lee, J. J. et al. Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma. Cell 177, 1842.e21–1857.e21 (2019).

5. Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal. Cell 173, 611.e17–623.e17 (2018).

Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation;Cancers;2024-01-24

2. A Tower of Babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS;Seminars in Hematology;2024-01

3. Molecular Pathogenesis of Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-01

4. Approach to High-Risk Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-01

5. Immune-Pathogenesis of Myeloma;Hematology/Oncology Clinics of North America;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3